Scientists from the United Kingdom (UK) have hailed their discovery of three genes linked to the most common form of breast cancer as groundbreaking.
The new discoveries' activity is unlikely to be affected by current treatments, such as tamoxifen, which target the oestrogen receptor. This could mean that they are potential targets for new drug treatments. Hormonal breast cancer, which is diagnosed in 37,000 women in the UK each year, accounts for four out of five of all breast tumors.Readmore
